Comparison of neural network and multiple linear regression as dissolution predictors

被引:31
作者
Sathe, PM
Venitz, J
机构
[1] US FDA, Off Gener Drugs, Div Bioequivalence, Rockville, MD 20855 USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
关键词
neural network; multiple linear regression; dissolution; prediction;
D O I
10.1081/DDC-120018209
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The predictive performance of an artificial neural network (NN) was compared with the first-order multiple linear regression (MLR) using mean dissolution data of 28 diltiazem immediate release tablet formulations. The performance was evaluated using "Weibull" function parameters alpha and beta. Weibull parameters were used as dissolution markers of the eight principal, mainly compositional, variables. The parameters were obtained by fitting the Weibull function to the mean (n = 12) dissolution profiles of 28 diltiazem hydrochloride tablet formulations. The generated set of 28 pairs of Weibull function parameters was evaluated for internal and external predictability using both the MLR and the artificial NN. A three-layered 8-5-2 feedforward NN was found to be an adequate descriptor of the dissolution data. Internal predictions were based on the data of 24 products. External predictions used the 24 product data to test four products not used in the training phase. The predictive performances of the two techniques were evaluated using bias (mean prediction error; MPE) and precision (mean absolute error; MAE). The study results suggested that, for the studied data set, NN is a superior internal and external predictor to MLR. [GRAPHICS] The artificial NN predicted order of the formulation composition variables, influencing the dissolution parameters as follows: hydrogenated oil > microcrystallinecellulose > ethyl cellulose > eudragit > hydroxypropylcellulose > coat > hydroxypropylmethylcellulose > Speed.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 10 条
[1]  
AVRON B, 1981, HDB ARTIFICIAL INTEL, P1
[2]  
*CHESH CORP, 1994, NEUR US GUID
[3]   APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT [J].
HUSSAIN, AS ;
YU, XQ ;
JOHNSON, RD .
PHARMACEUTICAL RESEARCH, 1991, 8 (10) :1248-1252
[4]   FEASIBILITY OF DEVELOPING A NEURAL NETWORK FOR PREDICTION OF HUMAN PHARMACOKINETIC PARAMETERS FROM ANIMAL DATA [J].
HUSSAIN, AS ;
JOHNSON, RD ;
VACHHARAJANI, NN ;
RITSCHEL, WA .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :466-469
[5]  
KHIANG PK, 2000, PHARMACEUT RES, V17, P1384
[6]  
NEIL G, 1979, ARTIF INTELL, P1
[7]   SOME SUGGESTIONS FOR MEASURING PREDICTIVE PERFORMANCE [J].
SHEINER, LB ;
BEAL, SL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :503-512
[8]  
Takayama K, 1999, PHARMACEUT RES, V16, P1
[9]  
WINSTON PH, 1984, ARTIF INTELL, P1
[10]  
1995, MICROMATH SCI WINDOW